Diabetes is complex, and the current model of care—measuring an A1C value every three months—does not capture the time spent in various blood glucose ranges or adequately characterize life with diabetes.
Real-time continuous glucose monitoring (RT-CGM) generates multiple points of glucose data, while also revealing patterns and trends to support discovery learning for the person living with diabetes. Dexcom CLARITY clinic software is a powerful tool for healthcare professionals (HCPs) to support treatment decisions.
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, is an Endocrine Clinical Pharmacy Specialist, and the CGM and Remote Monitoring Program Coordinator, at Cleveland Clinic Endocrinology & Metabolism Institute. As a CGM expert and the lead author of a 2020 paper focusing on technology integration,1 she is often asked questions about RT-CGM data interpretation, including: What do you do with the data? How do you interpret an ambulatory glucose profile (AGP) report? What are the International Consensus Guidelines on time in range (TIR)?
This video presentation will describe the need for both people living with diabetes and HCPs to review CGM data for treatment decisions and to support health behavior changes.
The key topics include:
Data interpretation for people living with diabetes
Data interpretation for HCPs
Watch this video to learn how you can use the DATAA model to quickly and systematically review RT-CGM data using Dexcom CLARITY software.
Download the convenient ICC Framework and the DATAA model reference tool described in the video.
The posting of sponsored information and content on this page should not be considered an AAFP endorsement or recommendation of the sponsor's products, services, policies, or procedures. The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods, or services.